sotalol has been researched along with Syndrome in 5 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms." | 7.72 | Effectiveness of sotalol treatment in symptomatic Brugada syndrome. ( Chen, S; Chiamvimonvat, N; Glatter, KA; Keating, M; Scheinman, MM; Wang, Q, 2004) |
| "Six patients with short QT syndrome, five of whom had received an implantable cardioverter-defibrillator (ICD) and one child, were tested with different antiarrhythmic drugs, including flecainide, sotalol, ibutilide, and hydroquinidine, to determine whether they could prolong the QT interval into the normal range and thus prevent symptoms and arrhythmia recurrences." | 5.11 | Short QT syndrome: pharmacological treatment. ( Antzelevitch, C; Bianchi, F; Borggrefe, M; Brugada, R; Calò, L; Gaita, F; Giustetto, C; Haissaguerre, M; Schimpf, R; Wolpert, C, 2004) |
| "We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms." | 3.72 | Effectiveness of sotalol treatment in symptomatic Brugada syndrome. ( Chen, S; Chiamvimonvat, N; Glatter, KA; Keating, M; Scheinman, MM; Wang, Q, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaita, F | 1 |
| Giustetto, C | 1 |
| Bianchi, F | 1 |
| Schimpf, R | 1 |
| Haissaguerre, M | 1 |
| Calò, L | 1 |
| Brugada, R | 1 |
| Antzelevitch, C | 1 |
| Borggrefe, M | 1 |
| Wolpert, C | 1 |
| Glatter, KA | 1 |
| Wang, Q | 1 |
| Keating, M | 1 |
| Chen, S | 1 |
| Chiamvimonvat, N | 1 |
| Scheinman, MM | 1 |
| Márquez, MF | 1 |
| Salica, G | 1 |
| Hermosillo, AG | 1 |
| Pastelín, G | 1 |
| Cárdenas, M | 1 |
| Severgnini, B | 1 |
| Maimone, G | 1 |
| Signorelli, G | 1 |
| Motta, P | 1 |
| Simpson, CF | 1 |
1 review available for sotalol and Syndrome
| Article | Year |
|---|---|
Drug therapy in Brugada syndrome.
Topics: Bundle-Branch Block; Cilostazol; Electrocardiography; Humans; Isoproterenol; Mexiletine; Sotalol; Sy | 2005 |
1 trial available for sotalol and Syndrome
| Article | Year |
|---|---|
Short QT syndrome: pharmacological treatment.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Death, Sudden, Cardiac | 2004 |
3 other studies available for sotalol and Syndrome
| Article | Year |
|---|---|
Effectiveness of sotalol treatment in symptomatic Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Genetic Predisp | 2004 |
[Beta blockers and the climateric syndrome].
Topics: Adult; Aged; Climacteric; Estrogens; Female; Humans; Middle Aged; Sotalol; Syndrome | 1985 |
Sotalol for the protection of turkeys from the development of -aminopropionitrile-induced aortic ruptures.
Topics: Aminopropionitrile; Animals; Aorta; Aortic Rupture; Blood Pressure; Drug Interactions; Heart Rate; H | 1972 |